Intravesical bacillus Calmette-Guérin combined with electromotive mitomycin for high-risk superficial bladder cancer - Commentary Journal Article

  

Author:	Bochner, B. H.
Article Title:	Intravesical bacillus Calmette-Guérin combined with electromotive mitomycin for high-risk superficial bladder cancer - Commentary
Keywords:	cancer survival; treatment outcome; overall survival; clinical trial; cancer recurrence; cancer combination chemotherapy; cancer growth; cancer risk; treatment planning; combined modality therapy; cancer staging; follow up; antineoplastic agent; bcg vaccine; antineoplastic activity; bladder cancer; urinary bladder neoplasms; high risk patient; risk assessment; disease progression; cystectomy; patient safety; long term care; mitomycin c; disease free interval; short survey; cancer control; transurethral resection; carcinoma, transitional cell; adjuvants, immunologic; antibiotics, antineoplastic; mitomycin; patient counseling; clinical trials; drug exposure; electric stimulation therapy; new drug
Journal Title:	Nature Clinical Practice Oncology
Volume:	3
Issue:	9
ISSN:	1743-4254
Publisher:	Nature Publishing Group
Date Published:	2006-09-01
Start Page:	474
End Page:	475
Language:	English
DOI:	10.1038/ncponc0588
PUBMED:	16955082
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-33748421510&partnerID=40&md5=5af5faf56b9bd77ece2b8e21da35480e
Notes:	--- - "Cited By (since 1996): 1" - "Export Date: 4 June 2012" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/26996